GSK cancer treatment meets trial endpoint
(Sharecast News) - GSK on Friday unveiled positive headline results from a Phase 3 trial of its Jemperli endometrial cancer drug.
Read more(Sharecast News) - GSK on Friday unveiled positive headline results from a Phase 3 trial of its Jemperli endometrial cancer drug.
Read more(Sharecast News) - GSK said the European Medicines Agency had validated its marketing authorisation application for momelotinib, a potential new oral treatment for the blood cancer myelofibrosis after meeting key endpoints in a Phase 3 trial.
Read moreNov 24 (Reuters) - An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.
Read more(Sharecast News) - Analysts at ShoreCap reiterated their 'buy' recommendation for shares of GSK despite news that its Blenrep treatment against multiple myeloma was set to be withdrawn from the US Market.
Read more(Correcting Fresnillo is gold and silver miner, and Comision Federal de Electricidad is Mexican state-owned power company.)
Read more(Alliance News) - London's FTSE 100 index was outperforming on Tuesday morning as a rising Brent price lifted its heavyweight oil stocks, while other equities were shaken by further Covid measures in China.
Read more(Alliance News) - GSK PLC on Tuesday said it has started the process to withdraw US marketing authorisation for its cancer drug, Blenrep, on the request of the US Food & Drug Administration.
Read more(Sharecast News) - British pharmaceutical giant GSK on Tuesday said it has started proceedings to pull US approval for its blood cancer drug Blenrep after it failed to meet the requirements of a late-stage trial.
Read more(Alliance News) - Stocks in London were called slightly higher on Tuesday, as a rising Brent oil price supported the FTSE 100 index, despite unease over Covid-related developments in China.
Read moreOil, mining stocks lead losses on FTSE 100
*Read moreWorker support includes bonuses, discounts, loans
*Read moreLONDON, Nov 16 (Reuters) - Britain’s agency that determines if medicines should be used in the National Health Service (NHS), has recommended stopping the use of five COVID-19 treatments, including Merck & Co's's antiviral pill for high-risk patients, citing cost-effectiveness concerns.
Read moreLONDON, Nov 15 (Reuters) - Since the pandemic emerged, more top drugmakers have made progress in improving access to medicines in the developing world, but those gains are largely limited to middle-income countries leaving the poorest behind, an analysis has found.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:
Read moreNews follows setback to GSK's blood cancer drug Blenrep
*Read more